Showing posts with label WEF. Show all posts
Showing posts with label WEF. Show all posts

Saturday, 10 June 2023

Moderna Vaccine Patented 9 Months Before Pandemic. Fauci-Baric’ Manmade SARS Viruses

 


Home Investigations Moderna Vaccine Patented 9 Months Before Pandemic. Thanks to the Fauci-Baric’ Manmade SARS Viruses

Moderna Vaccine Patented 9 Months Before Pandemic. Thanks to the Fauci-Baric’ Manmade SARS Viruses
22115
13
On the cover image the SARS masterminds Anthony Fauci and Ralph Baric beside the hot patent

by Fabio Giuseppe Carlo Carisio

VERSIONE IN ITALIANO

First published on March, 1, 2023

A disturbing document had already emerged proving the existence of an experimental gene serum based on messenger RNA against Covid-19 on 12 December 2019.

But nothing appears compared to the terrible secrets about the Spikevax vaccine produced by Big Pharma Moderna in Cambridge (Massachusetts, USA) thanks to the money of the Bill & Melinda Gates Foundation, the Pentagon (the American Department of Defense), and the collaboration with the Niaid (Institute Allergy and Infectious Diseases National Park) headed by Anthony Fauci, White House advisor on the SARS-Cov-2 pandemic.

Patent US10702600 for the vaccine candidate mRNA-1273 was in fact registered in its new composition on March 28, 2019.

That is 9 months before the official outbreak of the Covid-19 pandemic in China and the availability of the official Wuhan sequence MN908947.1, the virus initially called 2019-nCoV and then renamed by the World Health Organization SARS-Cov-2 to the strong genomic identity with SARS of 2003 (Severe Acute Respiratory Syndrome, or Severe Acute Respiratory Syndrome, when virus and disease were called the same).

The Fauci Covid-19 Dossier prepared by Dr. David E. Martin

This revelation comes from “The Fauci / COVID-19 Dossier” prepared by the American doctor David E. Martin who has developed a colossal study on US government-funded patents in relation to Coronaviruses since 2000, so much so that he suspects that SARS too in 2003 was built in the laboratory by microbiologist Ralph Baric of the Chapel Hill research center of the University of North Carolina (UNC) under the aegis of Fauci himself.

As we will see after long but inevitable premises, the registration of Moderna’s experimental vaccine on March 28, 2019, is also confirmed by the official history stored in the patent …

The discovery becomes even more disturbing in light of the fact that such research was conducted by the pharmaceutical company at the same time as Baric’s extremely dangerous experiments on SARS recombinant viruses conducted together with the director of the Infectious Diseases Research Center of the Wuhan Institute of Virology, Shi Zhengli, not randomly dubbed in China “BatWoman” for its coronavirus tests of horseshoe bats.

As anticipated before the online investigation in the book WuhanGates (December 2020), they would be the godfathers and progenitors of a huge plot of the New World Order of ancient British Masonic origin hatched under the sign of the Chinese Communists and American Democrats.

To it was also added the peremptory paws of Italy and Saudi Arabia aimed at global immunization projects preparatory to the health dictatorship of the Covid-19 emergency and the promotion of experimental anti-Covid gene serums for the enrichment of Big Pharma and speculation of the same investment funds that control the Weapons Lobby.

THE THERAPY OF DONNO AFFECTED BY THE MODERN GROUP

Before briefly summarizing the many information contained in the WuhanGates 40 report on the research of Professor Baric and Doctor Fauci, coordinator of all the riskiest and secret experiments on viruses and bacteriological weapons in the 28 American civil and military laboratories as evidenced by the exclusive investigation by Gospa News, we recall another of the mysteries in the ambiguous fight against Covid-19 revealed only by our online newspaper.

Moderna is part of that colossal international Zacks group that became interested in the highly effective therapy against Covid-19 of hyperimmune plasma developed by Professor Giuseppe De Donno and mysteriously vanished in the maze of health policy before his mysterious suicide.

It should also be remembered that the experimental gene sera were able to obtain emergency authorization in the USA, from the Food and Drug Administration which, however, in recent weeks gave definitive ok to Spikevax after having granted it to Comirnaty of Pizer-Biontech amid a thousand controversies for not having subjected the clinical data to the scrutiny of the independent Advisory Committee, and in the European Union by the European Medicines Agency (where they remain with a conditional marketing authorization as still experimental) only by virtue of two factors.

 

The pandemic has resulted in millions of deaths in the world with Covid-19 (in the minority died from Covid-19 and the majority from complications of other diseases), in Italy and in other countries mainly due to inadequate home and hospital care such as betrayal. use of cortisone or the disputed hydroxychloroquine (adopted by the protocols of the Piedmont Region) and the absence of drugs recognized as effective.

 

Therefore, the stop of the De Donno therapy, successfully carried out in over one hundred American university hospitals as recalled by the Johns Hopkins University in its defense, represented one of the obstacles in alternative treatments functional to the promotion of Moderna and other Big Pharma’s anti-Covid vaccines.

EXPERIMENTS ON CHIMERIC VIRUSES BEFORE 2003

«The National Institute of Health’s grant AI23946-08 issued to Dr. Ralph Baric at the University of North Carolina at Chapel Hill (officially classified as affiliated with Dr. Anthony Fauci’s NIAID by at least 2003) began the work on synthetically altering the Coronaviridae (the coronavirus family) for the express purpose of general research, pathogenic enhancement, detection, manipulation, and potential therapeutic interventions targeting the same. As early as May 21, 2000, Dr. Baric and UNC sought to patent critical sections of the coronavirus family for their commercial benefit».

As Martin’s dossier reports, in one of several articles derived from the work sponsored by this grant, «Baric published what he reported to be the SARS CoV full-length cDNA in which it was clearly stated that SAR CoV was based on a compound. of DNA segments».

«Using a panel of contiguous cDNAs that span the entire genome, we have assembled a full-length cDNA of the SARS-CoV Urbani strain, and have rescued molecularly cloned SARS viruses (infectious clone SARS-CoV) that contained the expected marker mutations inserted into the component clones».

SARS-Cov of 2003 was indicated with the name of Carlo Urbani, the researcher who was analyzing all its characteristics and died prematurely, struck down by the respiratory syndrome, like other scientists who died mysteriously while working on chimeric virus tests (Franc Plummer in Canada ) or when they tried to investigate the origin of these viruses and the gene sera then placed on the market after SARS-Cov-2 (Franco Trinca and Domenico Biscardi and finally the elderly Luc Montagnier).

For the sake of brevity, let’s skip all the references to the patents already mentioned in WuhanGates 40 and come to the conclusions of “The Fauci / Covid-19 Dossier” published by Dr. Martin: «In short, the U.S. Department of Health and Human Services was involved in the funding of amplifying the infectious nature of coronavirus between 1999 and 2002 before SARS was ever detected in humans».

The allusion to the virus that killed the Italian scientist Urbani’s intent on studying it is very heavy: even SARS 2003 could have been created in the laboratory!

The National Institutes of Health, Allergy, and Infectious Diseases worked on SARS Reverse Genetics. study AI059136-01. $1.7 million total costs, RS Baric, PI. 10% effort. 4/1/04- 3/31/09. The project develops a SARS-CoV full-length infectious cDNA, the development of SARS-CoV replicon particles expressing heterologous genes, and seeks to adapt SARS-CoV to mice, producing a pathogenic mouse model for SARS-CoV infection. Then, subsequently, the same NIAID carries out the research on Remodeling the SARS Coronavirus Genome Regulatory Network. RS Baric, PI 10% effort. 7/1/04-6/30/09. $2.1 million.

On November 22, 2004, the University of Hong Kong patents the spike protein associated with SARS on CoV and pursues US patent 7,491,489. But on June 2005 also the Pentagon’s DARPA (Defense Advanced Research Projects Agency) gets in on the game Synthetic Coronaviruses with the event Biohacking: Biological Warfare Enabling Technologies, organized in Washington, DC. and sponsored by DARPA/MITRE.

In 2008, funding for Biodefense Grant U54 AI057157 commences with $10,189,682 to UNC-Chapel Hill. Where, in the laboratories of North Carolina University, the experiments on chimeric superviruses will be carried out between 2014 and 2017, conducted in spite of Barack Obama’s moratorium on gains in function. And in 2010 the “Biodefense Grant U54 AI057157” continues with $ 8,747,142 to UNC-Chapel Hill (a non-competitive grant from NIAID). Patent issuance for the SARS coronavirus patients peaked after the outbreak in Asia with 391 patents issued.

We are talking about research funded by DARPA and the Pentagon precisely because they are dedicated to the construction of recombinant viruses, especially SARS infected with HIV as happened with the plasmids built by the Wuhan Institute of Virology thanks to funding from the European Commission chaired by Romano Prodi, with an increase in the charge. viral through the extremely dangerous Gain of Function technique and with “dual-use” purposes, i.e. vaccine but also a military bacteriological weapon: as is the SARS-Cov-2 according to a sworn report drawn up by Professor Montagnier and filed in legal action by two lawyers British.

«The CDC and NIAID entered into trade among States (including, but not limited to working with the University of North Carolina, Chapel Hill) and with foreign nations (specifically, the Wuhan Institute of Virology and the Chinese Academy of Sciences represented by Zheng-Li Shi) through U19AI109761 (Ralph S. Baric), U19AI107810 (Ralph S. Baric), and National Natural Science Foundation of China Award 81290341 (Zheng-Li Shi) et al. 2015-2016» reads in The Fauci / COVID-19 Dossier.

INTRIGUE WITH THE CIA AND US INTELLIGENCE

By October 2013, the Wuhan Institute of Virology 1 coronavirus S1 spike protein was described in NIAID’s funded work in China. This work involved NIAID, USAID, and Peter Daszak, the head of EcoHealth Alliance. This work, funded under R01AI079231, was pivotal in isolating and manipulating viral fragments selected from sites across China which contained a high risk for severe human response» remembered Martin.

In the same years, the Obama-Biden administration chooses lawyer Avril as deputy director from the Central Intelligence Agency, the American CIA counter-espionage which is also responsible for the supervision of military projects and which often uses the government agency USAID as a financial instrument for occult international operations. Haines, is an expert in drones but also in biological weapons.

Haines, subsequently, not only 2018 prophesied a coronavirus epidemic that could only be faced with a new “World Order” but will be one of the main protagonists of the Event 201 exercise held in mid-October in New York thanks to funding from the World Economic Forum by Klaus Schwab (Great Reset) and the Bill & Melinda Gates Foundation.

On the recommendation of American President Joseph Biden (her longtime political friend) on 21 January 2021 she was appointed by the Senate National Director of Intelligence from where she coordinates all 17 military and civil intelligence agencies and from where she searched, without success. for a rift between 007, to refute the thesis of the artificial origin of SARS-Cov-2.

MODERN STUDIES IN THE SAME YEARS

«By March 2015, both the virulence of the S1 spike protein and the ACE II receptor was known to present a considerable risk to human health. NIAID, EcoHealth Alliance, and numerous researchers lamented the fact that the public was not sufficiently concerned about coronavirus to adequately fund their desired research» the dossier still reads in reference to the experiments conducted in a “China-US affair” as Montagnier claimed on the origin of laboratory SARS-Cov-2.

In 2013, the Autonomous Diagnostics to Enable Prevention and Therapeutics (ADEPT) program awarded grant funding to Moderna Therapeutics for the development of a new type of vaccine based on messenger RNA. The initial DARPA grant was W911NF-13-1-0417» reveals Dr. Martin.

In 2015 Moderna signed an agreement for the development of vaccines with NIAID and executes it with the head of the developer and main inventor mRNA-1273 Giuseppe Ciaramella, says Dr. Martin referring to the “prototype” of the experimental antiCovid gene serum named in 2020 Spikevax.

 

ON 2016 NIH through Scripps Institute and Dartmouth College file patent application WO 2018081318A1 “Prefusion Coronavirus Spike Proteins and their Use” disclosing mRNA technology that overlaps (and is used in tandem with) Moderna’s technology. Lead Inventor Barney Scott Graham was well known to Moderna as he’s the person at NIH that Moderna “e-mailed” to get the sequence for SARS CoV-2 according to Moderna’s report. In addition, co-inventor Jason McLellan worked with Graham on a vaccine patent jointly owned by the Chinese government filed in Australia in 2013,

mRNA-1273 – the experimental vaccine developed by Moderna for COVID-19 – uses the LNP technology that Moderna thought it had licensed from Acuitas Therapeutics Inc., a firm developed by a former principal of Arbutus’ prior company Tekmira. That license did not authorize Moderna to use the technology for the COVID-19 vaccine.

M · CAM and Knowledge Ecology International (Martin’s reference bodies – ed) have independently confirmed that Moderna has violated U.S. law in failing to disclose the U.S. government’s funding interest in their patents and patent applications» reads in The Fauci / Covid-19 Dossier.

While this negligence impacts all of Moderna’s over 130 granted U.S. patents, it is particularly problematic for U.S. Patent 10,702,600 (‘600) which is the patent relating to, “a messenger ribonucleic acid (mRNA) comprising an open reading frame encoding a beta coronavirus (BetaCoV) S protein or S protein subunit formulated in a lipid nanoparticle».

We have dedicated a long investigation to the mysterious and dangerous biotechnologies with lipid nanoparticles with extensive scientific documentation in relation to the Comirnaty messenger RNA gene serum (“heterozygous twin” of Spikevax), produced by the New Yorker Pfizer with the German Biotech: the first partner of the London-based GSK run by a Microsoft director, the second funded by the same IT tycoon Gates.

THE VACCINE WAS PATENTED 9 MONTHS BEFORE THE PANDEMIC

In addition to the patents cited by the USPTO in their examination of ‘600, M·CAM has identified fourteen other issued patents preceding the ‘600 patent which were used by patent examiners to limit patents arising from the same funded research including patents sought by CureVac.

«In short, while Moderna enjoys hundreds of millions of dollars of funding allegiance and advocacy from Anthony Fauci and his NIAID, since its inception, it has been engaged in the illegal patent activity and demonstrated contempt for U.S. Patent law. To make matters worse, the U.S. Government has given it financial backing in the face of undisclosed infringement risks potentially contributing to the very infringement for which they are indemnified» concludes the medical author of The Fauci / Covid-19 Dossier.

But now comes the explosive statement: «The specific claims addressing the pivot to the SARS Coronavirus were patented on March 28, 2019 – 9 months before the SARS CoV-2 outbreak! Both the patent and the DARPA funding for the technology were disclosed in a scientific publications (New England Journal of Medicine) but the government funds were not acknowledged in the patent» is Dr. Martin’s shocking revelation.

The collaboration between Moderna and NIAID directed by Fauci in 2015 and the patent registration of the anti-Covid vaccine of 28 March 2019

The patent is updated on 7 July 2020 but was registered for the first time on 28 February 2020 but in continuation of the previous registration of 28 March 2019: the only one not to have changed the patent number (Pat. No.) as is seen in the historical extract of the vaccine.

“Continuation of aplication No. 16 / 368,270, filed on Mar.28,2019, which is a continuation of aplication No. 16 / 040,981, filed on Jul.20,2018, now Pat.No. 10,272,150, which is a continuation of aplication No. 15 / 674,599, filed on Aug.1,2017, now Pat.No.10,064,934, which is a continuation of aplication No.PCT / US2016 / 058327, filed on Oct.21,2016 “.

THE EXCHANGE OF DOCUMENTS IN DECEMBER 2019

Analogs were suspected of the existence of an experimental gene serum from Moderna before the official discovery of the Wuhan-Hu-1 virus, later identified as a new coronavirus initially named 2019-nCoV because the first cases were recorded in the populated city of Hubei precisely in that year, which was isolated and sequenced as Wuhan MN908947.1 on January 5, 2020.

The first to report the macroscopic anomaly was the British online investigative newspaper The Daily Exposé: «The first to report the macroscopic anomaly was the British online investigative newspaper The Daily Exposé. “A confidentiality agreement shows that potential coronavirus vaccine candidates were transferred from Moderna to the University of North Carolina in 2019, nineteen days before the emergence of the alleged virus causing Covid-19 in Wuhan, China wrote the British media on June 18, 2021.

The confidential agreement between Moderna and NIAID

The confidential agreement (like at the bottom of the page) states that providers ‘Moderna’ alongside the ‘National Institute of Allergy and Infectious Diseases (NIAID) agreed to transfer ‘mRNA coronavirus vaccine candidates’ developed and jointly-owned by NIAID and Moderna to recipients ‘The University of North Carolina at Chapel Hill’ on the 12th December 2019 wrote the editorial staff of Exposé publishing the extracts on pages 105 and 108.

The material transfer agreement was signed the December 12th, 2019 by Ralph Baric, Ph.D., at the University of North Carolina at Chapel Hill (the microbiologist of the laboratory chimeric SARS virus experiments – ed), and then signed by Jacqueline Quay, Director of Licensing and Innovation Support at the University of North Carolina on December 16th, 2019» adds the online newspaper, then asking inevitable questions…

PANDEMIC EMERGENCY, WAR IN UKRAINE, AND APOCALYPSE

So why was an mRNA coronavirus vaccine candidate developed by Moderna being transferred to the University of North Carolina on December 12th, 2019? Perhaps Moderna and the National Institute of Allergy and Infectious Diseases would like to explain themselves in a court of law?.

Questions similar to those I asked myself in an interview with TG6 journalist Anna Turletti in which I asked myself: “When will Bill Gates, the great director of dangerous research on laboratory SARS viruses in Wuhan and financier of Big Pharma, be arrested for the consequent vaccines? Is there only one magistrate on earth, only one, willing to do so in the face of this serious, precise, and consistent evidence of a diabolical plan?”.

This pandemic has been “planned for decades by Fauci and Gates”, also according to the lawyer Robert F. Kennedy jr, engaged through his association Children’s Health Defense in the fight against vaccines without adequate testing also inoculated to minors, as shamelessly admitted by the Pfizer itself in relation to the lack of data on myocardial risks for children under the age of 5.

But the manipulation of the viral load in the toxic protein Spike, as revealed by Colonel Lawrence Sellin, a former researcher in the bacteriological laboratories of the US Army of Fort Detrick Frederick (Maryland), could be the cause of similar toxicity of vaccines suitable to explain the reactions. serious or even fatal adverse events.

 

This pandemic was also functional to the world health dictatorship and therefore strategically preparatory to the Dictatorship of the New World Order and the imposition of the economic Great Reset, concretely feasible only through a real famine in the rich West and a Third World War such as the one that could derive from the conflict in Ukraine.

Certainly the last Great War on planet earth: before the Apocalypse!

Fabio Giuseppe Carlo Carisio
© COPYRIGHT GOSPA NEWS
prohibition of reproduction without authorization 
follow Gospa News on Telegram

.

Fabio G. C. Carisio

Fabio is Director and Editor of Gospa News; a Christian Information Journal.

Fabio Giuseppe Carlo Carisio, born on 24/2/1967 in Borgosesia, started working as a reporter when he was only 19 years old in the alpine area of Valsesia, Piedmont, his birth region in Italy. After studying literature and history at the Catholic University of the Sacred Heart in Milan, he became director of the local newspaper Notizia Oggi Vercelli and specialized in judicial reporting.

For about 15 years he is a correspondent from Northern Italy for the Italian newspapers Libero and Il Giornale, also writing important revelations on the Ustica massacre, a report on Freemasonry and organized crime.

With independent investigations, he collaborates with Carabinieri and Guardia di Finanza in important investigations that conclude with the arrest of Camorra entrepreneurs or corrupt politicians.

In July 2018 he found the counter-information web media Gospa News focused on geopolitics, terrorism, Middle East, and military intelligence.

His articles were published on many international media and website as SouthFront, Reseau International, Sputnik Italia, United Nation Association Westminster, Global Research, Kolozeg and more…

His investigations was quoted also by The Gateway Pundit, Tasnim and others

He worked for many years for the magazine Art & Wine as an art critic and curator.

VETERANS TODAY OLD POSTS

 
 
 
 

Saturday, 18 February 2023

MATHS TEACHER CHLOÉ FAMMERY Le WEF Forum économique mondial de Klaus Schwab - Agora TV


https://www.youtube.com/watch?v=jd2RyzoACT0

CHLOÉ FAMMERY Le WEF Forum économique mondial de Klaus Schwab : QUI est au Conseil de Fondation ?

5  

ChloeFra

1.71K followers

 4 months ago OCT 2022-FEB 2023

Clip clap clip clap, j'ai vraiment bien choisi mes chaussures aujourd'hui...
Malgré ces chaussures qui claquent, le vrombissement des voitures, cette journée super glauque et l'image surexposée à cause de la vitre fendilllée de mon téléphone, j'arrive à destination. J'arrive devant le WEF, le Forum économique mondial.

C'est le 2ème volet d'une enquête pour amateurs, sur le célèbre Forum champion des partenariats public-privé, dont le chef, Klaus Schwab, nous vante l' "indépendance' et l' "impartialité". Ce club pour milliardaires dont le fondateur dit pudiquement qu'il est le SEUL à "réunir tant de parties prenantes avec cette mission commune d'améliorer l'état du monde".

Sous la supervision du gouvernement suisse depuis sa création en 1971, le WEF est resté discret pendant presque 50 ans. Et puis le Forum a lancé avec la Fondation Bill & Melinda Gates et l'institut John Hopkins une simulation de pandémie en octobre 2019, mieux connue sous le nom de "Event 201". C'était 5 mois avant le lancement mondial de la [guerre du] Covid19, le 11 mars 2020.

Les 17 noms cités, et surtout les 17 fonctions correspondant à ces 17 noms de très hauts dirigeants qui composent le Conseil de Fondation du WEF sont-ils compatibles avec cette intégrité et cette impartialité tant vantées par l'ancien professeur d'économie devenu maître du monde ad interim ?

■ Sources :
• Ma vidéo du 25 janvier 2021 "Le WEF, Forum économique mondial de Klaus Schwab - Genève"
https://odysee.com/@Chloe_F:b/le-wef-forum-conomique-mondial-de-2:2

• Ma vidéo du 13 avril 2020 "Covid19 : La Suisse au coeur des décisions mondiales"
https://odysee.com/@Chloe_F:b/covid19-la-suisse-au-coeur-des-d-cisions:d

• Gavi (Global Alliance for vaccines and immunization) https://www.gavi.org/fr/notre-alliance/modele-de-fonctionnement/modele-de-partenariat-de-gavi

• CEPI (Coalition for Epidemic Preparedness Innovations)
https://cepi.net/about/whyweexist

• Gavi et CEPI sont des alliances public-privé qui ont été lancées par le WEF
- Gavi (2000)
https://www.centreforpublicimpact.org/case-study/gavi-vaccine-alliance
- CEPI (2017)
https://www.weforum.org/press/2017/01/cepi-initiative-aims-to-prepare-vaccines-to-speed-up-global-response-to-epidemics

LA MISSION OFFICIELLE DU WEF
Le Forum économique mondial est l'Organisation internationale de coopération public-privé.
Il a été créé en 1971 en tant que fondation à but non lucratif et a son siège à Genève, en Suisse.
"Le Forum engage les principaux dirigeants politiques, commerciaux, culturels et autres de la société à façonner les programmes mondiaux, régionaux et industriels."
"Il est indépendant, impartial et n'est lié à aucun intérêt particulier."
"L'intégrité morale et intellectuelle est au cœur de tout ce qu'il fait."
https://www.weforum.org/about/world-economic-forum

• Le Forum économique mondial (WEF) est une Organisation internationale depuis 2015
https://widgets.weforum.org/history/2015.html

CONSEIL DE FONDATION DU WEF
(29 membres, dont les 17 suivants)
https://www.weforum.org/about/leadership-and-governance
• Klaus Schwab, Fondateur et président du WEF
• Fabiola Gianotti, Directrice générale du CERN
• Larry Fink, Fondateur et directeur de BlackRock
• Orit Gadiesh, Directrice de Bain & Company
• Kristalina Giorgieva, Directrice du FMI
• Christine Lagarde, Présidente de la BCE, ex-présidente du FMI
• Al Gore, Actionnaire de BlackRock, Vice-président des USA (1993-2001), directeur de GIM (General Investment Management), réalisateur de "Une vérité qui dérange"
• Chrystia Freeland, Vice-premiere ministère du Canada et Ministre des finances du Canada
• Peter Maurer, Président de la Croix Rouge, démissionnaire en septembre 2022
• Ngozi Okonjo-Iweala, Présidente de l'OMC

• David M. Rubenstein, co-Fondateur et co-Président du groupe Carlyle
• Léo Rafael Reif, Président du MIT
• Mark Schneider, PDG de Nestlé
• Julie Sweet, PDG de Accenture
• Thomas Bubert, DG de AXA
• Joe Kaeser, Président du Conseil de surveillance de Siemens Energy
• Jim Hagemann, Président de Siemens
• Peter Brabeck :
- Vice-président du Conseil de Fondation du WEF
- Participe au Bilderberg 2011
https://fr.m.wikipedia.org/wiki/Liste_des_membres_du_groupe_Bilderberg
- Président de Nestlé (2005-2017), il considère l'eau comme un bien marchand et annonce en 2005 vouloir la privatiser
https://fr.m.wikipedia.org/wiki/Peter_Brabeck-Letmathe
- Actuel président de Gesda
https://gesda.global/gesda-extends-its-gratitude-to-the-swiss-government-for-10-year-validation
- Membre de la Commission Attali, et est aussi vice-président du conseil d'administration de L'Oréal et membre du Conseil d’administration de Salt.
https://fr.m.wikipedia.org/wiki/Peter_Brabeck-Letmathe

• Le MIT à la source des certificats de vaccination sous la peau (Quantum Dot Dye)
https://news.mit.edu/2019/storing-vaccine-history-skin-1218

• La Commission Trilatérale est un cercle mondialiste, créé en 1973 et initié par les principaux dirigeants du groupe Bilderberg et du CFR, parmi lesquels Henry Kissinger, David Rockefeller, Zbiniew Brzezinski
https://fr.m.wikipedia.org/wiki/Commission_trilat%C3%A9rale

 

 

Tuesday, 16 November 2021

ELITE'S WORLD WAR III ON THE HUMAN SPECIES FOR A LUCIFERIAN WORLD ORDER - GOD IS DEAD, TRUST BILL GATES' TRANSHUMAN COLLECTIVIST CAPITALISM!

           From the USSR to the USA SOVIET CAPITALIST, COLLECTIVIST, AND FASCIST DICTATORSHIP



FROM DEMOCRACY TO FASCISM - AARON RUSSO (MURDERED BY CANCER)

 * THE ELITE ENGINEERED A FAKE PANDEMIC AND REAL BIO-WEAPONS CALLED VACCINES TO SET UP THE USASCCFD - USA SOVIET CAPITALIST, COLLECTIVIST, AND FASCIST DICTATORSHIP 

 

TAVISTOCK-GATES STRATEGY 17.11.2021

3 SCAREMONGERING ANNOUNCEMENTS IN LESS THAN 5 MINUTES?


UN-GATES PLANDEMIC


* NWO, LUCIFERIAN USASCCFD, GOD IS DEAD, TRUST BILL GATES' ROBOTISED TRANSHUMAN COLLECTIVIST CAPITALISM!

   YEA, I GOT IT, I PUT ON 10KG, AND I AM HIDING FROM DOCTORS OF THE NATIONAL HARM SYSTEM (NHS) WHO ARE TRYING HARD TO KILL GATES ME SINCE 2020! 



* TRUST BANKS, TOTALITARIANISM, UNO AGENDA 21, DAVOS WORLD ECONOMIC GENOCIDE FORUM, GREAT RESET, TRANSHUMANISM, LABTQ...!

                1984 is now and for ever to stay!


 Forum économique mondial - Décoder Davos (Quadrillage traduction)

June 28th, 2021220 views
  •  https://odysee.com/@Roms17:d/Forum-%C3%A9conomique-mondial---D%C3%A9coder-Davos-(Quadrillage-traduction):9

     

    Channel profile picture

    ON NOUS A FINALEMENT TOUT DIT, MAIS NOUS NE SOMMES TOUJOURS QUE DES ABRUTIS POUR LA PLUPART!
    BAFS

     


     WHEN WE BELIEVE GOD CAME TO EARTH AND DIED ON A JEWISH-ROMAN CROSS, IT IS EASY TO BELIEVE IN CHRIST BILL GATES AND HIS COVID-19 GREAT RESET AND THE EFFICACY OF BIO-WEAPONS JABS OF THE SYNAGOGUE OF SATAN!!!

                UN-ISRAEL HAS PROMISED WORSE TO COME!

     

              US PILOT DAN HANLEY, 9/11 WHISTLEBLOWER!

    Friday, 17 September 2021

    WEF, WHO, UNICEF, COVAX, GAVI, CEPI, GATES PLANDEMICIANS OF ENGINEERED VIRUSES AND BIO-WEAPONS JABS FOR THE WHOLE WORLD - DAVOS PLOTTERS JAN 2020.

     By Jamie Ducharme

    [TIME]  September 9, 2021 7:00 AM EDT

    In January 2020, world leaders and industry titans gathered in Switzerland for the World Economic Forum’s annual Davos conference. Much of the conversation centered around the mysterious new coronavirus that had emerged in Wuhan, China, a month earlier, and had at that point infected nearly 300 people in four countries.

    Two of the conference’s attendees were Dr. Seth Berkley, CEO of Gavi, the Vaccine Alliance, and Dr. Richard Hatchett, CEO of the Coalition for Epidemic Preparedness Innovations (CEPI). Over scotch and nachos one night, Berkley and Hatchett got to talking about worst-case scenarios. “‘If this does evolve into a pandemic,’” Hatchett remembers discussing, “‘how are we going to get [vaccine] doses to developing countries?’”

    Hatchett, who served in both the George W. Bush and Obama administrations, oversaw the U.S.’ vaccine donations to other countries during the 2009 H1N1 pandemic. As COVID-19 began to spread in early 2020, he didn’t know if vaccines would prove necessary. But he knew from experience that, if they did, wealthy countries were likely to buy out and hoard whatever limited supply of doses came together—unless “aggressive action,” as he describes it, was taken to stop them.

    In March 2020, as the COVID-19 virus continued to spread across the planet, Hatchett wrote a white paper laying the groundwork for a solution: a global initiative to support the development of COVID-19 vaccines through advance agreements with numerous pharmaceutical companies, and to distribute shots to countries around the world, whether or not those nations could pay for them. Those ideas ultimately helped inform COVAX, the global vaccine distribution project co-led by CEPI, Gavi and the World Health Organization (WHO), with logistical support from UNICEF.

    “It was a breathtakingly important initiative,” says Lawrence Gostin, a WHO adviser and a professor of global health law at Georgetown University. “The first of its kind ever in the world.”

    But it was far from perfect. The very issues that Hatchett feared—vaccine nationalism, self-interest, unequal access to limited supply—soon scarred COVAX’s idealistic facade. While COVAX struggled to secure funding, wealthy countries struck out on their own, signing unilateral deals with vaccine makers and buying up limited supply. And as wealthy countries rocketed ahead, COVAX’s pledge to distribute vaccines in poor countries at the same time they rolled out in rich countries faltered.

    As of Sept. 8, COVAX had distributed more than 240 million vaccine doses in 139 countries. That sounds like a lot—and it is, relative to any other public-health crisis in history—but it will almost certainly leave COVAX well short of its goal of distributing 2 billion doses by the end of 2021. The initiative now expects to have access to 1.4 billion doses by the end of 2021 and to hit 2 billion in the first quarter of 2022, the group said in a statement.

    COVAX is largely placing the blame on the shoulders of the world’s richest countries, some of which have purchased more than enough vaccines for their populations. While many wealthy countries have begun to donate unneeded doses to COVAX, “The global picture of access to COVID-19 vaccines,” COVAX representatives said in the statement, “is unacceptable.”

    Indeed, in the U.S., about half the population is now fully vaccinated. In other wealthy countries, like the U.K., an even larger share of citizens have gotten their shots. By contrast, experts have estimated it could take until 2023 for many lower-income countries to vaccinate the majority of their populations, even with COVAX’s assistance. Meanwhile, people are dying, economies are struggling and the virus continues to mutate.

    “As an ideal, [COVAX was] an A+,” Gostin says. “In its implementation, a C.” Flawed though it may be, COVAX represents a step toward international health equity—and improving its implementation could be lifesaving not just during this pandemic, but also the next one.

    The plan to ensure no country was left behind

    COVAX’s funding model is complex, but the basic plan went like this: Wealthy countries would purchase at least some of their vaccines through the COVAX facility, even if they also signed their own deals on the side. With that group purchasing power, COVAX would negotiate cost-effective deals with various vaccine makers, and participating countries would have an insurance policy in case their own vaccine procurement plans failed. Meanwhile, another arm of COVAX would collect donations from nonprofits, businesses and countries to support the donation of billions of doses to low- and middle-income nations.

    This model enabled COVAX to spread its bets by backing numerous vaccine makers; that way, plans would be in place with whichever companies ultimately succeeded in developing an effective vaccine, and it wouldn’t matter as much if some failed. The group’s donation arm was meant to guarantee that poorer countries would get access to vaccines at the same time as richer ones. COVAX’s initial goal was to provide enough vaccines to protect some 20% of each country’s population, before any participating country got more than that.

    COVAX officials always knew wealthy countries would make some deals with vaccine makers on their own, Gavi’s Berkley says. But the group’s goal was to streamline the process enough to avoid a total free-for-all. “Let’s just say there’s no COVAX,” Berkley says. “You have 204 countries all going after the same manufacturers in a competitive fashion, trying to do deals, undercutting each other.” Centralizing a significant chunk of that activity, COVAX’s leaders hoped, would prevent lower-income countries from getting left behind. But some wealthy countries, most notably the U.S. and China, initially opted out of COVAX entirely.

    Meanwhile, COVAX was struggling to sign major deals. As a brand-new organization, it didn’t have any funding in the bank. And many countries—even those that pledged to be part of the initiative—were slow to turn promises into actual financial contributions. It didn’t help that wealthy countries weren’t only depriving COVAX of much-needed funding by relying on their own side deals, but also buying up large chunks of the vaccine supply before the shots were even available.

    After the Biden Administration took over from Donald Trump in early 2021, it did shift polices, pledging $4 billion to COVAX over two years. (China eventually pledged to buy enough shots through COVAX to vaccinate 1% of its population.) But by then the damage was done. As soon as highly effective vaccines were authorized in late 2020, manufacturers began shipping much of their supply directly to the U.S. and other rich countries.

    Some experts say it was naive for COVAX’s leaders to even pretend that rich countries would whole-heartedly buy into a system that aimed to vaccinate the rest of the world at the same rate. “Do you think [20% vaccinated by the end of 2021] would be considered a success for the U.S.? No,” says Mark Eccleston-Turner, a medical law and ethics expert at Keele University in the U.K. “Having such a low target perpetuated this injustice.”

    Read more: Biden Is Reasserting the U.S.’ Role in Vaccine Distribution. Is It Enough?

    Why COVAX had to play catch-up

    In the summer of 2020, members of the WHO’s ethics committee met with leaders from COVAX to discuss its population-based allocation plan. Immediately, says someone who attended the meeting (and who asked to remain anonymous so they could openly discuss it without fear of reprisal), members of the WHO’s ethics committee expressed concerns. Why were all countries set to receive the same proportional number of vaccines, when need varied drastically? (A WHO spokesperson said the discussions were confidential and did not confirm or deny that account.)

    Some experts—both part of and independent from the WHO ethics committee—say it would have been more sensible to distribute vaccines based on the severity of COVID-19 outbreaks in various countries, rather than by a fixed measure of population. “You want to put the hose on the fire,” Gostin says. That is, COVAX could make the biggest impact by bringing vaccines to countries with the largest amounts of death and disease, rather than by distributing shots uniformly, he argues.

    Of course, there’s no guarantee that an in-need country will actually be able to use the doses it is given. Already, many poor countries that have received doses from COVAX have wasted large amounts of vaccine because they lack the cold storage and health infrastructure needed to distribute them.

    But more importantly, argues CEPI’s Hatchett, the needs of a country at any given moment are not enough to establish an ethical distribution of vaccines, since it’s impossible to predict when or if a country will struggle with a future COVID-19 outbreak. For example, India was doing relatively well during the first year of the pandemic, and as a result, the Serum Institute of India (SII), a massive facility located in Pune and licensed to produce AstraZeneca-Oxford University and Novavax’s shots, felt comfortable committing to produce hundreds of millions of doses that COVAX could distribute to other countries. But in the spring of 2021, India was pummeled by COVID-19, and the nation decided to temporarily pause all exports and focus on distributing domestically made shots at home, in hopes of minimizing damage associated with the surge. That left COVAX about 190 million doses short of its goals by the end of June 2021.

    The delay at Serum Institute is “one of the largest reasons [COVAX] has been behind schedule,” Gian Gandhi, the COVAX coordinator for UNICEF’s supply division, says. That raises the question of why COVAX relied so heavily on a single manufacturer.

    While COVAX was trying to scrape together money in the summer of 2020, one of its partners, the Bill & Melinda Gates Foundation, along with GAVI, signed a deal with the Serum Institute to ensure that 100 million vaccine doses would be available for low- and middle-income countries during the first half of 2021; they later expanded the agreement to cover an additional 100 million doses. “Gates was comfortable working with SII because they’d done a lot of these types of deals [with them] and felt this was an affordable way to proceed,” Gandhi says. The Gates Foundation’s support was critical for COVAX, but it made SII its primary supplier and, to a large extent, dictated its ability to provide vaccines. “I’m not sure that there would have been another way, because there wasn’t any other money,” Gandhi admits.

    Read more: Modi Never Bought Enough COVID-19 Vaccines for India. Now the Whole World Is Paying

    Things might have turned out differently if global economic leaders like the U.S. put up money from the beginning, potentially inspiring other wealthy nations to do the same. In that alternate reality, perhaps COVAX would have had enough cash on hand to sign bigger deals with vaccine makers and to secure a more diverse array of manufacturers, boosting supply and safeguarding itself against unexpected delays.

    Even better, of course, would be if COVAX hadn’t had to scramble for funding during an ongoing pandemic. The true blame, medical law expert Eccleston-Turner says, lies with the international community’s failure to create something like COVAX before it was needed. A global vaccine hub could have been developed after the 2009 H1N1 pandemic, which revealed similar disparities in vaccine access, but it never came together. “In the intervening years between 2009 and COVID, we did very little to solve this problem, to prevent this from being a problem in the future,” Eccleston-Turner says. “COVAX was always playing catch up.”

    It’s hard to imagine any organization built on the fly in the midst of a public-health crisis overcoming centuries of entrenched issues in global health. It’s not COVAX’s fault that some countries simply don’t have the public-health infrastructure required to store, distribute and manufacture vaccines, nor that centuries of inequality have left some countries able to vaccinate their populations many times over while others cannot afford to sign a single contract.

    COVAX couldn’t single-handedly change the way high-income nations carry out their foreign relations and political maneuvers, which were always going to include some amount of nationalism, Gostin says. Some rich countries that bought enough vaccines for themselves haven’t been shy about requesting even more from COVAX. The U.K., as the Associated Press reported, asked for nearly half a million doses in June. “The primary function of a sovereign state is to serve the interests of its own population and you’re always fighting against that,” Eccleston-Turner says.

    If there’s a silver lining…

    COVAX has indisputably helped get vaccines to countries that otherwise could not have purchased them, and faster than has ever been done before. “There’s no question, if you compare it to the [H1N1 pandemic]…we’ve done much better this time,” Berkley says. “But of course, it’s not good enough.”

    Dr. Ann Lindstrand, unit head for the WHO’s Essential Programme on Immunization, agrees that distribution has been a “disappointment,” but also argues that the groundwork laid by COVAX will have a significant positive impact moving forward. “In the end,” says Lindstrand, “COVAX will prove itself as a very important mechanism for global equitable distribution when we have a common threat.”

    COVAX has made many mistakes. But perhaps the biggest would be using its errors as license to scrap it completely. If the COVAX saga has shown anything, it is that the world can’t afford to wait for a solution to be built once a problem has already arrived. There must be a tool standing ready—funded and organized and able to spring into action—the moment a new health crisis emerges.

    Now that we have the basis of such a tool, the international community needs to commit to funding it, so it doesn’t have to beg in the middle of a crisis, says Ezekiel Emanuel, vice provost for global initiatives at the University of Pennsylvania. Gostin adds that COVAX could stand to be improved operationally—for example, it could be more transparent about who is making its decisions and why, something that can get lost in the shuffle of an initiative co-led by four different organizations. Eccleston-Turner says COVAX and other global health groups also need to pay more attention to building out manufacturing and public-health infrastructure in countries that need it, rather than simply parachuting in and offering vaccines that many don’t have the capacity to use to their full extent.

    There’s room for improvement, to be sure. But Gostin says it’s more sensible to improve upon the existing—if imperfect—COVAX model, rather than starting from scratch.

    “If we didn’t have COVAX,” he says, “we’d have to invent it.”